Case report: Treatment with Phesgo® in a patient receiving hemodialysis
IntroductionPatients with metastatic HER2-positive breast cancer have multiple therapeutic options. However, most are not studied in the renal replacement therapy (RRT) setting.Case reportWe report the use of Phesgo® (subcutaneous fixed-dose combination of trastuzumab and pertuzumab) combined with e...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-05-01
|
| Colección: | Frontiers in Oncology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1348343/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|